SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-12-034308
Filing Date
2012-02-01
Accepted
2012-02-01 16:04:36
Documents
1
Group Members
ADVENT HEALTHCARE & LIFE SCIENCES III A LIMITEDPARTNERSHIPADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIPADVENT INTERNATIONAL LLCADVENT PARTNERS HLS III LIMITED PARTNERSHIPAHLS III GP LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 d295058dsc13da.htm SC 13D/A 122659
  Complete submission text file 0001193125-12-034308.txt   124514
Mailing Address 75 STATE STREET BOSTON MA 02109
Business Address 75 STATE STREET BOSTON MA 02109 6179519400
ADVENT INTERNATIONAL CORP/MA (Filed by) CIK: 0001034196 (see all company filings)

IRS No.: 042840139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85739 | Film No.: 12562680
SIC: 2834 Pharmaceutical Preparations